Antibody (2)
Launched (2)
Mouse (2)
Human IgG1 (2)
Unconjugated (2)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
RSV-MY2231 | HEK293 | Monoclonal Anti-HRSV Glycoprotein (RSV-G) Antibody, Human IgG1 (8E6) (MALS verified) | |||||
RSV-MY2232 | HEK293 | Monoclonal Anti-HRSV Glycoprotein (RSV-G) Antibody, Human IgG1 (8G9) (MALS verified) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Fepixnebart | LY-3016859 | Phase 2 Clinical | Eli Lilly And Company | Diabetic Neuropathies; Osteoarthritis, Knee; Diabetic Nephropathies; Osteoarthritis; Low Back Pain | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



